V
Vertex Pharmaceuticals
Boston, United States
Founded 1989 NASDAQ: VRTX
Nanomedicine Gene Therapy Delivery Lipid Nanoparticles Protein Nanoparticles Cell Therapy Nano Nano-Bio
About
Global biotechnology company focused on cystic fibrosis and gene editing therapies
Company Details
- Type
- public
- Employees
- 5000+
- Funding
- Public
Key Products
- Trikafta
- Casgevy
- Kalydeco